文献速递前列腺癌

不可逆电穿孔与高强度聚焦超声用于前列腺癌消融的真实世界安全性与有效性比较

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation.
PubMed 文献 · Urology · 2023-02-02

该研究通过两项系统文献综述与荟萃分析,比较不可逆电穿孔(IRE)与高强度聚焦超声(HIFU)消融前列腺癌的安全性和有效性。共纳入55篇文献(IRE 22篇,HIFU 33篇)。荟萃分析显示IRE患者平均PSA降幅更低、治疗后靶区内活检阴性率更高、维持勃起功能率更高;两种方法严重不良事件发生率均低,功能结局和生活质量维持良好。

要点

  • IRE患者平均PSA降幅低于HIFU患者,但靶区内治疗后活检阴性率和勃起功能维持率高于HIFU患者。
  • 两种方法严重不良事件(≥III级)发生率范围为0%至8%,常见不良事件为尿路感染、排尿困难、血尿和尿失禁或尿急。
  • IRE和HIFU均与良好的功能结局及治疗后生活质量维持相关。

核心结论

  • IRE和HIFU均产生良好的有效性结局,并发症率低,对患者排尿和勃起功能影响轻微,并维持整体生活质量。
  • 这些真实世界发现可帮助指导临床决策并改善前列腺癌患者的疾病管理。

研究设计与样本

  • 开展了两项关于IRE和HIFU的系统文献综述(SLR)和荟萃分析(MA),遵循PRISMA指南。
  • 检索PubMed和EMBASE数据库,由独立评审员评估文献 eligibility 并提取安全性和有效性数据。
  • 系统文献综述共纳入55篇出版物(IRE 22篇;HIFU 33篇)。
  • 在数据质量和可用性允许时,使用常规方法和随机/混合效应模型进行荟萃分析,并进行了质量评估。

主要发现

  • 荟萃分析显示,IRE患者平均PSA水平降低百分比低于HIFU患者。
  • 荟萃分析显示,IRE患者治疗后靶区内活检阴性率高于HIFU患者。
  • 荟萃分析显示,IRE患者勃起功能维持率高于HIFU患者。
  • 大多数报告的不良事件(AE)为可比且轻微(I、II级),最常见报告的是尿路感染、排尿困难、血尿和尿失禁或尿急。
  • 经历严重AE(≥III级)的患者比例在IRE后为0至8%,HIFU后为0至8%。

关键数值与推荐

  • 荟萃分析针对治疗后靶区内活检阴性、前列腺特异性抗原(PSA)水平降低、勃起功能、尿控和AE发生率结局进行。
  • 严重AE(≥III级)比例范围为0至8%(IRE和HIFU)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the comparative safety and effectiveness of 2 prostate cancer treatment ablation modalities: irreversible electroporation (IRE) and high-intensity focused ultrasound (HIFU). METHODS: Two systematic literature reviews (SLRs) and meta-analyses (MAs) on IRE and HIFU were conducted in accordance with PRISMA guidelines. Searches were conducted in PubMed and EMBASE. Independent reviewers assessed literature eligibility and abstracted safety and effectiveness data. Oncological, safety, functional, and quality of life (QOL) outcomes were examined for each technology. MAs were conducted where data quality and availability allowed, using normal methods and a random/mixed effects model, and quality assessments performed. RESULTS: Fifty-five publications (n = 22 IRE; n = 33 HIFU) were included in the SLRs, and MAs were conducted on negative in-field post-procedure biopsy, prostate-specific antigen (PSA) level reduction, potency, urinary continence, and AE rate outcomes. MAs revealed that IRE patients had lower mean percent PSA level reductions, higher mean rates of in-field negative post-treatment biopsy, and higher rates of potency maintenance than HIFU patients. Most adverse events (AEs) reported were comparable and minor (Grades I, II), with urinary tract infection, dysuria, hematuria, and incontinence or urgency most frequently reported. The proportion of patients experiencing a severe AE (≥Grade III) ranged from 0 to 8% after IRE and HIFU. Both modalities were associated with positive functional outcomes as well as maintenance of QOL after treatment. CONCLUSIONS: Both IRE and HIFU were found to produce favorable effectiveness outcomes and have low complication rates while minimally impacting patient urinary and erectile function and maintaining overall QOL. These real-world findings can help guide clinical decision making and improve disease management for patients with prostate cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Cribbs KA, Manning EF, Zhou J, et al. Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation. Urology. 2023. PMID: 36736917. doi:10.1016/j.urology.2023.01.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。